发明名称 ANTI-CYTOKINE MEDIATION DISEASE AGENT MAKING VITAMIN E DERIVATIVE ACTIVE INGREDIENT
摘要 PROBLEM TO BE SOLVED: To provide a pharmaceutical composition effective in preventing or treating diseases in which an inflammatory cytokine mediates, and which develop or are aggravated, especially septic shock, acute organopathy and organ failure, and various organopathies produced by ischemic reperfusion. SOLUTION: The anti-cytokine mediation disease agent includes water-soluble vitamin E derivatives shown by general formula of drawing, or their salts permitted in pharmacology as an active ingredient. In the formula, R<SB>1</SB>and R<SB>2</SB>same or differently denote a hydrogen atom or a methyl group, R<SB>3</SB>and R<SB>5</SB>differently denote a hydrogen atom, or an SH compound having S binding or its ester (however, excluding cysteamine), R<SB>4</SB>denotes a hydroxy group, an N-substituted amino acid or its ester (however, excluding aminoethane sulfonic acid, aminoethane sulfinic acid) or an amine compound. COPYRIGHT: (C)2011,JPO&INPIT
申请公布号 JP2011153139(A) 申请公布日期 2011.08.11
申请号 JP20110000208 申请日期 2011.01.04
申请人 OITA UNIV;OGA RESEARCH:KK 发明人 OGATA KAZUMI;NOGUCHI TAKAYUKI;YOKOI ISAO;IWASAKA HIDEO;HAGIWARA SATOSHI;SHINGU CHIHIRO;MATSUMOTO SHIGEKIYO;HASEGAWA TERU;KOGA HIRONORI;KUDO KIYOHIRO;KUSAKA JUNYA
分类号 A61K31/355;A61K31/4025;A61K31/4045;A61P1/04;A61P1/18;A61P3/02;A61P3/10;A61P7/00;A61P9/10;A61P11/00;A61P13/02;A61P17/08;A61P19/00;A61P19/02;A61P19/08;A61P19/10;A61P21/00;A61P25/00;A61P29/00;A61P31/04;A61P33/06;A61P35/00;A61P35/02;A61P37/06;A61P43/00 主分类号 A61K31/355
代理机构 代理人
主权项
地址